Iovance Biotherapeutics Inc (OQ:IOVA)

Business Focus: Bio Diagnostics & Testing

Latest 10 SEC filings (by transaction date) for IOVA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 4th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 20/24 Feb 20/24 Mcpeak Merrill A Direct Ownership Common Stock P - Open market or private purchase 250,000 $9.15
Feb 20/24 Feb 20/24 Dukes Iain D. Direct Ownership Common Stock P - Open market or private purchase 32,000 $9.15
Feb 20/24 Feb 20/24 Rothbaum Wayne P. Indirect Ownership Common Stock P - Open market or private purchase 5,000,000 $9.15
Jan 18/24 Jan 16/24 Vogt Frederick G Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -20,834  
Jan 18/24 Jan 16/24 Vogt Frederick G Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -6,530 $8.37
Jan 18/24 Jan 16/24 Vogt Frederick G Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,834  
Jan 18/24 Jan 16/24 Graf Finckenstein Friedrich Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -2,813  
Jan 18/24 Jan 16/24 Graf Finckenstein Friedrich Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,577 $8.37
Jan 18/24 Jan 16/24 Graf Finckenstein Friedrich Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,813  
Jan 18/24 Jan 16/24 Bilinsky Igor Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -2,813  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for IOVA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 4th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 20/24 Feb 20/24 Mcpeak Merrill A Direct Ownership Common Stock P - Open market or private purchase 250,000 $9.15
Feb 20/24 Feb 20/24 Dukes Iain D. Direct Ownership Common Stock P - Open market or private purchase 32,000 $9.15
Feb 20/24 Feb 20/24 Rothbaum Wayne P. Indirect Ownership Common Stock P - Open market or private purchase 5,000,000 $9.15
Jan 18/24 Jan 16/24 Vogt Frederick G Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -20,834  
Jan 18/24 Jan 16/24 Vogt Frederick G Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -6,530 $8.37
Jan 18/24 Jan 16/24 Vogt Frederick G Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,834  
Jan 18/24 Jan 16/24 Graf Finckenstein Friedrich Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -2,813  
Jan 18/24 Jan 16/24 Graf Finckenstein Friedrich Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,577 $8.37
Jan 18/24 Jan 16/24 Graf Finckenstein Friedrich Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,813  
Jan 18/24 Jan 16/24 Bilinsky Igor Direct Ownership Restricted Stock Units M - Exercise or conversion exempt under rule 16b-3 -2,813  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $IOVA

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Exact Sciences (OQ:EXAS)
Guardant Health (OQ:GH)
VolitionRX (A:VNRX)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.